Walleye Trading’s Legend Biotech LEGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$490K Sell
27,100
-15,300
-36% -$292K ﹤0.01% 2604
2025
Q4
$922K Buy
42,400
+31,000
+272% +$888K ﹤0.01% 2429
2025
Q3
$372K Buy
11,400
+1,600
+16% +$59.1K ﹤0.01% 2951
2025
Q2
$348K Buy
9,800
+3,700
+61% +$120K ﹤0.01% 2899
2025
Q1
$207K Sell
6,100
-2,700
-31% -$96.8K ﹤0.01% 3070
2024
Q4
$286K Buy
+8,800
New +$365K ﹤0.01% 3023
2024
Q1
Sell
-2,900
Closed -$174K 5074
2023
Q4
$174K Buy
2,900
+2,100
+263% +$133K ﹤0.01% 3864
2023
Q3
$53.7K Buy
+800
New +$55.6K ﹤0.01% 4188
2023
Q2
Sell
-4,000
Closed -$193K 4943
2023
Q1
$193K Sell
4,000
-2,300
-37% -$112K ﹤0.01% 3530
2022
Q4
$314K Sell
6,300
-12,800
-67% -$620K ﹤0.01% 3201
2022
Q3
$779K Buy
19,100
+6,300
+49% +$296K ﹤0.01% 2469
2022
Q2
$704K Buy
+12,800
New +$541K ﹤0.01% 2575

Other funds holding LEGN

Walleye Trading's LEGN Position: Q1 2026 in Review

Walleye Trading increased its Legend Biotech (LEGN) stake by 162% in Q1 2026, buying an estimated $150K and bringing the position to 12,744 shares worth $231K. The position accounts for ﹤0.01% of the portfolio, ranked #3040.

Walleye Trading first reported a position in LEGN in Q3 2023 and has held it in 6 quarters since. 189 funds tracked by Wall St. Rank hold LEGN as of Q1 2026.

  • Walleye Trading held 12,744 shares of Legend Biotech worth $231K as of Q1 2026.
  • Walleye Trading bought 7,886 Legend Biotech shares in Q1 2026, an estimated $150K.
  • Legend Biotech made up ﹤0.01% of Walleye Trading's portfolio in Q1 2026, its #3040 holding.
  • Walleye Trading first reported a position in Legend Biotech in Q3 2023 and has held it in 6 quarters since.
  • 189 funds tracked by Wall St. Rank held Legend Biotech as of Q1 2026.

Based on Walleye Trading's 13F filing for Q1 2026, filed 11 May 2026.